News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lachey Jennifer
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2022 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 1,417 shares
@ $61.37, valued at
$87k
Sold 1,009 shares
@ $62.32, valued at
$62.9k
Sold 2,315 shares
@ $63.5, valued at
$147k
Sold 559 shares
@ $64.15, valued at
$35.9k
Exercised 5,300 options to buy
@ $0.3, valued at
$1.6k
|
|
| 04/06/2022 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 7,950 shares
@ $60, valued at
$477k
Exercised 7,950 options to buy
@ $0.3, valued at
$2.4k
|
|
| 03/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 1,073 shares
@ $51.5, valued at
$55.3k
Sold 1,378 shares
@ $52.35, valued at
$72.1k
Sold 199 shares
@ $53.1, valued at
$10.6k
Exercised 2,650 options to buy
@ $0.3, valued at
$795 |
|
| 01/25/2022 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $46.3, valued at
$2.3M
|
|
| 01/13/2022 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 320 shares
@ $52.01, valued at
$16.6k
Sold 1,196 shares
@ $53.56, valued at
$64.1k
Sold 1,134 shares
@ $54.45, valued at
$61.7k
Exercised 2,650 options to buy
@ $0.3, valued at
$795 |
|
| 01/07/2022 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 2,650 shares
@ $60, valued at
$159k
Exercised 2,650 options to buy
@ $0.3, valued at
$795 |
|
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2021 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 15,900 shares
@ $60, valued at
$954k
Sold 739 shares
@ $58.73, valued at
$43.4k
Sold 4,561 shares
@ $59.78, valued at
$272.7k
Exercised 15,900 options to buy
@ $0.3, valued at
$4.8k
Exercised 5,300 options to buy
@ $0.3, valued at
$1.6k
|
|
| 11/05/2021 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 10,600 shares
@ $50, valued at
$530k
Exercised 10,600 options to buy
@ $0.3, valued at
$3.2k
|
|
| 06/25/2021 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Exercised 6,500 options to buy
@ $0.3, valued at
$2k
|
|
| 06/15/2021 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 1,533 shares
@ $50.37, valued at
$77.2k
Sold 898 shares
@ $51.73, valued at
$46.5k
Sold 219 shares
@ $52.13, valued at
$11.4k
Exercised 2,650 options to buy
@ $0.3, valued at
$795 |
|
| 05/13/2021 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 2,650 shares
@ $50, valued at
$132.5k
Exercised 2,650 options to buy
@ $0.3, valued at
$795
Exercised 6,220 options to buy
@ $0.11, valued at
$684.2
Exercised 500 options to buy
@ $0.3, valued at
$150 |
|
| 04/14/2021 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 998 shares
@ $59.1, valued at
$59k
Sold 3,473 shares
@ $59.99, valued at
$208.3k
Sold 729 shares
@ $61.08, valued at
$44.5k
Sold 100 shares
@ $61.72, valued at
$6.2k
Exercised 5,300 options to buy
@ $0.3, valued at
$1.6k
|
|
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2020 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 241,222 options to buy
@ $16, valued at
$3.9M
|
|
|
|